• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种裂解性噬菌体的特性鉴定及其与K2解聚酶对高毒力菌株52145的联合裂解作用的证明

Characterization of a Lytic Bacteriophage and Demonstration of Its Combined Lytic Effect with a K2 Depolymerase on the Hypervirulent Strain 52145.

作者信息

Pertics Botond Zsombor, Kovács Tamás, Schneider György

机构信息

Department of Medical Microbiology and Immunology, Medical School, University of Pécs, Szigeti St. 12., H-7624 Pécs, Hungary.

Department of Biotechnology, Nanophagetherapy Center, Enviroinvest Corporation, Kertváros St. 2., H-7632 Pécs, Hungary.

出版信息

Microorganisms. 2023 Mar 6;11(3):669. doi: 10.3390/microorganisms11030669.

DOI:10.3390/microorganisms11030669
PMID:36985241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10051899/
Abstract

is a nosocomial pathogen. Among its virulence factors is the capsule with a prominent role in defense and biofilm formation. Bacteriophages (phages) can evoke the lysis of bacterial cells. Due to the mode of action of their polysaccharide depolymerase enzymes, phages are typically specific for one bacterial strain and its capsule type. In this study, we characterized a bacteriophage against the capsule-defective mutant of the nosocomial 52145 strain, which lacks K2 capsule. The phage showed a relatively narrow host range but evoked lysis on a few strains with capsular serotypes K33, K21, and K24. Phylogenetic analysis showed that the newly isolated Klebsiella phage 731 belongs to the genus in the family; it has a 31.084 MDa double-stranded, linear DNA with a length of 50,306 base pairs and a G + C content of 50.9%. Out of the 79 open reading frames (ORFs), we performed the identification of , coding for a trimeric tail fiber protein with putative capsule depolymerase activity, along with the mapping of other putative depolymerases of phage 731 and homologous phages. Efficacy of a previously described recombinant K2 depolymerase (B1dep) was tested by co-spotting phage 731 on strains, and it was demonstrated that the B1dep-phage 731 combination allows the lysis of the wild type 52145 strain, originally resistant to the phage 731. With phage 731, we showed that B1dep is a promising candidate for use as a possible antimicrobial agent, as it renders the virulent strain defenseless against other phages. Phage 731 alone is also important due to its efficacy on strains possessing epidemiologically important serotypes.

摘要

是一种医院病原体。在其毒力因子中,荚膜在防御和生物膜形成中起重要作用。噬菌体可以引起细菌细胞的裂解。由于其多糖解聚酶的作用方式,噬菌体通常对一种细菌菌株及其荚膜类型具有特异性。在本研究中,我们对一种针对医院52145菌株的荚膜缺陷突变体的噬菌体进行了表征,该突变体缺乏K2荚膜。该噬菌体显示出相对较窄的宿主范围,但能在一些具有荚膜血清型K33、K21和K24的菌株上引起裂解。系统发育分析表明,新分离的克雷伯氏菌噬菌体731属于该科的属;它有一个31.084 MDa的双链线性DNA,长度为50306个碱基对,G + C含量为50.9%。在79个开放阅读框(ORF)中,我们鉴定了编码具有假定荚膜解聚酶活性的三聚体尾丝蛋白的基因,同时对噬菌体731和同源噬菌体的其他假定解聚酶进行了定位。通过将噬菌体731与菌株共点样,测试了先前描述的重组K2解聚酶(B1dep)的功效,结果表明B1dep - 噬菌体731组合能够裂解原本对噬菌体731耐药的野生型52145菌株。利用噬菌体731,我们表明B1dep是一种有前途的抗菌剂候选物,因为它使有毒菌株对其他噬菌体失去防御能力。单独的噬菌体731因其对具有重要流行病学血清型的菌株的功效也很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/3540c7bd0320/microorganisms-11-00669-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/7a7a7b0a6c7e/microorganisms-11-00669-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/88a63876903a/microorganisms-11-00669-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/a9d30e9a506f/microorganisms-11-00669-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/73fb37a833fc/microorganisms-11-00669-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/c7e545d2e466/microorganisms-11-00669-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/4415bd8272f7/microorganisms-11-00669-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/3540c7bd0320/microorganisms-11-00669-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/7a7a7b0a6c7e/microorganisms-11-00669-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/88a63876903a/microorganisms-11-00669-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/a9d30e9a506f/microorganisms-11-00669-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/73fb37a833fc/microorganisms-11-00669-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/c7e545d2e466/microorganisms-11-00669-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/4415bd8272f7/microorganisms-11-00669-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddaa/10051899/3540c7bd0320/microorganisms-11-00669-g007.jpg

相似文献

1
Characterization of a Lytic Bacteriophage and Demonstration of Its Combined Lytic Effect with a K2 Depolymerase on the Hypervirulent Strain 52145.一种裂解性噬菌体的特性鉴定及其与K2解聚酶对高毒力菌株52145的联合裂解作用的证明
Microorganisms. 2023 Mar 6;11(3):669. doi: 10.3390/microorganisms11030669.
2
Isolation and Characterization of a Novel Lytic Bacteriophage against the K2 Capsule-Expressing Hypervirulent Strain 52145, and Identification of Its Functional Depolymerase.一株针对表达K2荚膜的高毒力菌株52145的新型裂解性噬菌体的分离、鉴定及其功能解聚酶的识别
Microorganisms. 2021 Mar 21;9(3):650. doi: 10.3390/microorganisms9030650.
3
A novel phage putative depolymerase, Depo16, has specific activity against K1 capsular-type .一种新型噬菌体假定解聚酶 Depo16 对 K1 荚膜型具有特异性活性。
Appl Environ Microbiol. 2024 Apr 17;90(4):e0119723. doi: 10.1128/aem.01197-23. Epub 2024 Mar 29.
4
Comparison of the therapeutic potential of bacteriophage KpV74 and phage-derived depolymerase (β-glucosidase) against Klebsiella pneumoniae capsular type K2.噬菌体 KpV74 与噬菌体衍生的解聚酶(β-葡萄糖苷酶)治疗 K 型肺炎克雷伯菌的潜力比较
Virus Res. 2022 Dec;322:198951. doi: 10.1016/j.virusres.2022.198951. Epub 2022 Sep 30.
5
Mechanistic Insights into the Capsule-Targeting Depolymerase from a Klebsiella pneumoniae Bacteriophage.对一株肺炎克雷伯氏菌噬菌体的囊靶向解聚酶的机制见解。
Microbiol Spectr. 2021 Sep 3;9(1):e0102321. doi: 10.1128/Spectrum.01023-21. Epub 2021 Aug 25.
6
Identification of three capsule depolymerases in a bacteriophage infecting Klebsiella pneumoniae capsular types K7, K20, and K27 and therapeutic application.鉴定一株能感染肺炎克雷伯菌 K7、K20 和 K27 荚膜型的噬菌体中的三种荚膜降解酶及其治疗应用。
J Biomed Sci. 2023 May 20;30(1):31. doi: 10.1186/s12929-023-00928-0.
7
Isolation of a bacteriophage specific for a new capsular type of Klebsiella pneumoniae and characterization of its polysaccharide depolymerase.一种针对新型荚膜型肺炎克雷伯菌的噬菌体的分离及其多糖解聚酶的特性研究。
PLoS One. 2013 Aug 2;8(8):e70092. doi: 10.1371/journal.pone.0070092. Print 2013.
8
Characterisation of Bacteriophage-Encoded Depolymerases Selective for Key Capsular Exopolysaccharides.针对关键荚膜多糖的噬菌体编码解聚酶的特性研究。
Front Cell Infect Microbiol. 2021 Jun 18;11:686090. doi: 10.3389/fcimb.2021.686090. eCollection 2021.
9
Comparative genome analysis of novel Podoviruses lytic for hypermucoviscous Klebsiella pneumoniae of K1, K2, and K57 capsular types.对K1、K2和K57荚膜型高黏液性肺炎克雷伯菌具有裂解作用的新型短尾病毒的比较基因组分析。
Virus Res. 2018 Jan 2;243:10-18. doi: 10.1016/j.virusres.2017.09.026. Epub 2017 Oct 5.
10
Phage resistance formation and fitness costs of hypervirulent mediated by K2 capsule-specific phage and the corresponding mechanisms.由K2荚膜特异性噬菌体介导的高毒力噬菌体抗性形成、适应性代价及相应机制
Front Microbiol. 2023 Jul 19;14:1156292. doi: 10.3389/fmicb.2023.1156292. eCollection 2023.

引用本文的文献

1
Isolation and characterization of a novel phage targeting Klebsiella pneumoniae K2 capsular type.一种靶向肺炎克雷伯菌K2荚膜型的新型噬菌体的分离与鉴定。
Braz J Microbiol. 2025 Jun 6. doi: 10.1007/s42770-025-01707-9.
2
Genomic analysis and therapeutic efficacy evaluation of bacteriophage PK2420 for pneumonia caused by hypervirulent (K20 serotype).噬菌体PK2420对高毒力(K20血清型)肺炎的基因组分析及治疗效果评估
mSystems. 2025 May 20;10(5):e0163224. doi: 10.1128/msystems.01632-24. Epub 2025 Apr 16.
3
Isolation and Characterization of a Novel Lytic Phage N22 and Its Effect on Drug-Resistant .

本文引用的文献

1
Comparison of the therapeutic potential of bacteriophage KpV74 and phage-derived depolymerase (β-glucosidase) against Klebsiella pneumoniae capsular type K2.噬菌体 KpV74 与噬菌体衍生的解聚酶(β-葡萄糖苷酶)治疗 K 型肺炎克雷伯菌的潜力比较
Virus Res. 2022 Dec;322:198951. doi: 10.1016/j.virusres.2022.198951. Epub 2022 Sep 30.
2
Isolation and Characterization of vB_kpnM_17-11, a Novel Phage Efficient Against Carbapenem-Resistant .分离和鉴定 vB_kpnM_17-11,一种有效对抗碳青霉烯类耐药菌的新型噬菌体。
Front Cell Infect Microbiol. 2022 Jul 5;12:897531. doi: 10.3389/fcimb.2022.897531. eCollection 2022.
3
Characterization and Functional Studies of a Novel Depolymerase Against K19-Type .
新型裂解性噬菌体N22的分离、鉴定及其对耐药菌的作用
Infect Drug Resist. 2025 Apr 10;18:1807-1818. doi: 10.2147/IDR.S515363. eCollection 2025.
4
Capsular Polysaccharide as a Potential Target in Hypervirulent and Drug-Resistant Treatment.荚膜多糖作为高毒力和耐药性治疗的潜在靶点
Infect Drug Resist. 2025 Mar 3;18:1253-1262. doi: 10.2147/IDR.S493635. eCollection 2025.
5
A New Insight into Phage Combination Therapeutic Approaches Against Drug-Resistant Mixed Bacterial Infections.噬菌体联合治疗耐药混合细菌感染方法的新见解
Phage (New Rochelle). 2024 Dec 18;5(4):203-222. doi: 10.1089/phage.2024.0011. eCollection 2024 Dec.
6
Lytic Spectra of Tailed Bacteriophages: A Systematic Review and Meta-Analysis.有尾噬菌体的裂解谱:系统评价与荟萃分析
Viruses. 2024 Dec 4;16(12):1879. doi: 10.3390/v16121879.
7
Isolation and preliminary characterization of a novel bacteriophage vB_KquU_φKuK6 that infects the multidrug-resistant pathogen .一种新型噬菌体vB_KquU_φKuK6的分离及其初步特性鉴定,该噬菌体可感染多重耐药病原体。
Front Microbiol. 2024 Oct 15;15:1472729. doi: 10.3389/fmicb.2024.1472729. eCollection 2024.
8
A Novel Phage against Bearing a Unique Gene of Intergeneric Origin.一种携带独特属间起源基因的新型噬菌体。
Curr Issues Mol Biol. 2024 Aug 23;46(9):9312-9329. doi: 10.3390/cimb46090551.
9
Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic .噬菌体鸡尾酒和噬菌体-抗生素协同作用对致病菌的抗菌效果。
mSystems. 2024 Sep 17;9(9):e0060724. doi: 10.1128/msystems.00607-24. Epub 2024 Aug 21.
10
Relationship between biofilm formation and antibiotic resistance of and updates on antibiofilm therapeutic strategies.生物膜形成与抗生素耐药性之间的关系以及抗生物膜治疗策略的最新进展。
Front Cell Infect Microbiol. 2024 Feb 23;14:1324895. doi: 10.3389/fcimb.2024.1324895. eCollection 2024.
一种新型抗K19型解聚酶的表征及功能研究
Front Microbiol. 2022 Jun 22;13:878800. doi: 10.3389/fmicb.2022.878800. eCollection 2022.
4
Identification of a phage-derived depolymerase specific for KL47 capsule of Klebsiella pneumoniae and its therapeutic potential in mice.鉴定一种针对肺炎克雷伯菌 KL47 荚膜的噬菌体衍生的解聚酶及其在小鼠中的治疗潜力。
Virol Sin. 2022 Aug;37(4):538-546. doi: 10.1016/j.virs.2022.04.005. Epub 2022 May 2.
5
Genome Sequences of 22 T1-like Bacteriophages That Infect .22种感染……的T1样噬菌体的基因组序列
Microbiol Resour Announc. 2022 May 19;11(5):e0122121. doi: 10.1128/mra.01221-21. Epub 2022 Apr 7.
6
Development of Capsule Polysaccharide-Conjugated Vaccine Candidates Using Phage Depolymerases.利用噬菌体脱聚合物酶开发囊多糖偶联疫苗候选物。
Front Immunol. 2022 Mar 21;13:843183. doi: 10.3389/fimmu.2022.843183. eCollection 2022.
7
Isolation, characterization, and genome analysis of bacteriophage P929 that could specifically lyase the KL19 capsular type of Klebsiella pneumoniae.分离、鉴定和基因组分析能特异性裂解肺炎克雷伯菌 KL19 荚膜型的噬菌体 P929。
Virus Res. 2022 Jun;314:198750. doi: 10.1016/j.virusres.2022.198750. Epub 2022 Mar 18.
8
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection.肺炎克雷伯氏菌临床分离株中 PemIK(PemK/PemI)型 II TA 系统在裂解性噬菌体感染中的作用。
Sci Rep. 2022 Mar 16;12(1):4488. doi: 10.1038/s41598-022-08111-5.
9
Effective phage cocktail to combat the rising incidence of extensively drug-resistant sequence type 16.有效噬菌体鸡尾酒疗法应对广泛耐药 16 型序列的上升发病率。
Emerg Microbes Infect. 2022 Dec;11(1):1015-1023. doi: 10.1080/22221751.2022.2051752.
10
Lytic Phages against ST11 K47 Carbapenem-Resistant Klebsiella pneumoniae and the Corresponding Phage Resistance Mechanisms.裂解噬菌体对抗 ST11 K47 碳青霉烯类耐药肺炎克雷伯菌及其相应的噬菌体耐药机制。
mSphere. 2022 Apr 27;7(2):e0008022. doi: 10.1128/msphere.00080-22. Epub 2022 Mar 8.